Workflow
SONOSCAPE(300633)
icon
Search documents
开立医疗(300633) - 关于2025年员工持股计划非交易过户完成的公告
2025-12-26 08:26
深圳开立生物医疗科技股份有限公司(以下简称"公司")于 2025 年 9 月 4 日召开了第四届董事会第十次会议、第四届监事会第九次会议,于 2025 年 9 月 23 日召开了 2025 年第一次临时股东大会,会议分别审议通过了《关于公司 2025 年员工持股计划(草案)及其摘要的议案》等相关议案。具体内容详见公司在巨 潮资讯网(http://www.cninfo.com.cn)披露的相关公告。 证券代码:300633 证券简称:开立医疗 公告编号:2025-057 深圳开立生物医疗科技股份有限公司 关于 2025 年员工持股计划非交易过户完成的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 根据《关于上市公司实施员工持股计划试点的指导意见》《深圳证券交易所 上市公司自律监管指引第 2 号——创业板上市公司规范运作》等相关规定,公司 2025 年员工持股计划(以下简称"本员工持股计划")已完成标的股票过户,现 将相关事项公告如下: 一、本员工持股计划的股票来源及数量 本员工持股计划股票来源为公司回购专用证券账户回购的开立医疗 A 股普 通股股票。 公司 ...
股票行情快报:开立医疗(300633)12月25日主力资金净卖出740.52万元
Sou Hu Cai Jing· 2025-12-25 13:22
证券之星消息,截至2025年12月25日收盘,开立医疗(300633)报收于26.75元,上涨0.34%,换手率 0.76%,成交量3.28万手,成交额8763.77万元。 该股主要指标及行业内排名如下: 12月25日的资金流向数据方面,主力资金净流出740.52万元,占总成交额8.45%,游资资金净流入77.14 万元,占总成交额0.88%,散户资金净流入663.39万元,占总成交额7.57%。 近5日资金流向一览见下表: 开立医疗2025年三季报显示,前三季度公司主营收入14.59亿元,同比上升4.37%;归母净利润3351.11 万元,同比下降69.25%;扣非净利润2399.1万元,同比下降72.14%;其中2025年第三季度,公司单季度 主营收入4.95亿元,同比上升28.42%;单季度归母净利润-1351.92万元,同比上升78.05%;单季度扣非 净利润-1588.57万元,同比上升76.92%;负债率24.22%,投资收益207.82万元,财务费用-3830.36万 元,毛利率60.36%。开立医疗(300633)主营业务:医疗诊断及治疗设备的自主研发、生产与销售。 该股最近90天内共有13家 ...
股票行情快报:开立医疗(300633)12月24日主力资金净卖出606.30万元
Sou Hu Cai Jing· 2025-12-24 14:15
证券之星消息,截至2025年12月24日收盘,开立医疗(300633)报收于26.66元,上涨1.41%,换手率 0.55%,成交量2.37万手,成交额6315.8万元。 12月24日的资金流向数据方面,主力资金净流出606.3万元,占总成交额9.6%,游资资金净流出575.43 万元,占总成交额9.11%,散户资金净流入1181.73万元,占总成交额18.71%。 近5日资金流向一览见下表: 该股主要指标及行业内排名如下: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 开立医疗2025年三季报显示,前三季度公司主营收入14.59亿元,同比上升4.37%;归母净利润3351.11 万元,同比下降69.25%;扣非净利润2399.1万元,同比下降72.14%;其中2025年第三季度,公司单季度 主营收入4.95亿元,同比上升28.42%;单季度归母净利润-1351.92万元,同比上升78.05%;单季度扣非 净利润-1588.57万元,同比上升76.92%;负债率24.22%,投资收益207.82万元,财务费用-3830.36万 元 ...
开立医疗:公司微创外科、心血管介入业务发展顺利,近两年均取得较高增速
Mei Ri Jing Ji Xin Wen· 2025-12-24 01:21
每经AI快讯,有投资者在投资者互动平台提问:董秘你好,请问贵司新业务IVUS 导管耗材和硬镜设备 是否导入顺利? (记者 张明双) 开立医疗(300633.SZ)12月24日在投资者互动平台表示,公司微创外科、心血管介入业务发展顺利, 近两年均取得较高增速。 ...
开立医疗(300633.SZ):公司微创外科、心血管介入业务发展顺利
Ge Long Hui· 2025-12-24 01:16
Group 1 - The core viewpoint of the article is that the company, KaiLi Medical, has experienced significant growth in its minimally invasive surgery and cardiovascular intervention businesses over the past two years [1] Group 2 - The company reported that both business segments have achieved high growth rates [1]
股票行情快报:开立医疗(300633)12月23日主力资金净卖出369.65万元
Sou Hu Cai Jing· 2025-12-23 13:49
该股主要指标及行业内排名如下: | 指标 | 开立医疗 | 医疗器械行业均值 | 行业排名 | | --- | --- | --- | --- | | 总市值 | 113.76亿元 | 107.86亿元 | 27 125 | | 净资产 | 31.19亿元 | 38.83亿元 | 46 125 | | 净利润 | 3351.11万元 | 2.1亿元 | 75 125 | | 市盈率(动) | 254.6 | 78.7 | 88 125 | | 市净率 | 3.65 | 3.73 | 88 125 | | 毛利率 | 60.36% | 51.02% | 50 125 | | 净利率 | 2.3% | 9.59% | 89 125 | | ROE | 1.07% | 0.23% | 85 125 | 证券之星消息,截至2025年12月23日收盘,开立医疗(300633)报收于26.29元,下跌1.35%,换手率 0.54%,成交量2.35万手,成交额6213.08万元。 12月23日的资金流向数据方面,主力资金净流出369.65万元,占总成交额5.95%,游资资金净流出 170.45万元,占总成交额2.74%,散 ...
股票行情快报:开立医疗(300633)12月22日主力资金净卖出423.05万元
Sou Hu Cai Jing· 2025-12-22 15:01
开立医疗2025年三季报显示,前三季度公司主营收入14.59亿元,同比上升4.37%;归母净利润3351.11 万元,同比下降69.25%;扣非净利润2399.1万元,同比下降72.14%;其中2025年第三季度,公司单季度 主营收入4.95亿元,同比上升28.42%;单季度归母净利润-1351.92万元,同比上升78.05%;单季度扣非 净利润-1588.57万元,同比上升76.92%;负债率24.22%,投资收益207.82万元,财务费用-3830.36万 元,毛利率60.36%。开立医疗(300633)主营业务:医疗诊断及治疗设备的自主研发、生产与销售。 证券之星消息,截至2025年12月22日收盘,开立医疗(300633)报收于26.65元,上涨0.26%,换手率 0.48%,成交量2.06万手,成交额5503.53万元。 12月22日的资金流向数据方面,主力资金净流出423.05万元,占总成交额7.69%,游资资金净流入78.72 万元,占总成交额1.43%,散户资金净流入344.32万元,占总成交额6.26%。 近5日资金流向一览见下表: 该股主要指标及行业内排名如下: 以上内容为证券之星据公开信 ...
海南封关首日见闻:第一批“执行例外措施”保税维修业务落地
Zhong Guo Xin Wen Wang· 2025-12-19 04:02
Core Viewpoint - The official launch of the Hainan Free Trade Port on December 18 marks a significant milestone with the first batch of medical equipment undergoing bonded maintenance under the "executive exception measures" policy, indicating a breakthrough in the bonded maintenance industry for medical devices in Hainan [1] Group 1: Policy Implementation - The first batch of medical equipment parts, valued at 347,300 yuan, was imported by Kaili Biomedical Technology (Haikou) Co., Ltd. and successfully cleared customs [1] - The customs authorities provided comprehensive support throughout the process, from policy consultation to customs declaration guidance [1] - The bonded maintenance business will operate within the Haikou National High-tech Industrial Development Zone, catering to global after-sales needs for medical equipment, thus establishing a complete business chain of "global order, Hainan maintenance, global delivery" [1] Group 2: Customs Support and Collaboration - The Haikou Customs quickly coordinated with local departments to address challenges and facilitate the smooth execution of this representative business [2] - A one-on-one connection mechanism was established between customs officials and the enterprise to understand its business model and import plans, leading to tailored customs and regulatory solutions [2] - Customs officials acted as "policy advisors," assisting the company in navigating the complexities of the new policy and ensuring efficient completion of the declaration process [2] Group 3: Policy Benefits - The executive exception measures cover a wide range of products, enhancing service efficiency for enterprises and supporting industrial development [3] - The customs clearance process has been simplified, eliminating the need for import license verification and requiring only the selection of an additional product attribute code during declaration [3] - The new model achieves efficient regulation through a combination of automated system control and targeted manual checks, facilitating a seamless regulatory experience [3]
第一批符合执行例外措施的保税维修业务落地
Hai Nan Ri Bao· 2025-12-19 03:28
Core Viewpoint - The implementation of the "two ends outside" bonded maintenance policy in Hainan Free Trade Port allows for the repair of medical equipment, enhancing service efficiency and reducing costs for overseas clients [2][3]. Group 1: Policy Implementation - A batch of medical equipment parts, specifically endoscope components, has been approved for bonded maintenance under the new policy [2]. - The policy is part of the Ministry of Commerce's announcement regarding the Hainan Free Trade Port, which includes a list of goods allowed for "two ends outside" bonded maintenance [3]. Group 2: Company Overview - Kaili Biomedical Technology (Haikou) Co., Ltd., a subsidiary of Shenzhen Kaili Biomedical Technology Co., Ltd., is leading the initiative in the bonded maintenance of medical devices [2]. - Kaili Medical is recognized as a leading enterprise in the ultrasound and endoscope sectors, with products exported globally [2]. Group 3: Market Demand and Efficiency - The international market's demand for timely and professional equipment maintenance is increasing, prompting the need for efficient repair solutions [2]. - The establishment of a global repair center in Haikou allows for direct receipt of equipment from various regions, including the EU, US, and Middle East, significantly improving service response times and reducing maintenance costs [3].
股票行情快报:开立医疗(300633)12月18日主力资金净卖出173.26万元
Sou Hu Cai Jing· 2025-12-18 14:09
12月18日的资金流向数据方面,主力资金净流出173.26万元,占总成交额3.05%,游资资金净流入 177.28万元,占总成交额3.12%,散户资金净流出4.03万元,占总成交额0.07%。 近5日资金流向一览见下表: | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-12-18 | 26.67 | 0.19% | -173.26万 | -3.05% | 177.28万 | 3.12% | -4.03万 | -0.07% | | 2025-12-17 | 26.62 | 0.41% | -191.20万 | -3.51% | 84.91万 | 1.56% | 106.28万 | 1.95% | | 2025-12-16 | 26.51 | 0.11% | -11.16万 | -0.27% | 266.45万 | 6.38% | -255.28万 | -6.11% | | 2025-12-15 | 26.48 | ...